Radiation Oncology Clinical Trial
Official title:
Development and Assessment of a Novel, Systematic Radiation Treatment Plan Evaluation Learning Tool for Radiation Oncology Residents
This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.
Status | Not yet recruiting |
Enrollment | 20 |
Est. completion date | September 1, 2025 |
Est. primary completion date | September 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - The pilot program will be open to radiation oncology resident physicians that are in their PGY-2, PGY-3, or PGY-4 year. - All residents must have completed a breast cancer-specific radiation oncology rotation at least 3 months prior to enrollment in the pilot program in order to be eligible. Exclusion Criteria: -The study will not include any special populations. |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital Cancer Center | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Objective Examination Score | Analyzed with a paired samples t-test. | Up to 8 weeks | |
Secondary | Oncology Resident Confidence Rate | Scored using Likert scales and analyzed with non-parametric tests. | Week 1 - 8 | |
Secondary | Oncology Resident Perceived Competence Rate | Scored using Likert scales and analyzed with non-parametric tests. | Week 1 - 8 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT03734952 -
Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy
|
N/A | |
Recruiting |
NCT05176964 -
Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
|
||
Recruiting |
NCT03466424 -
Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer
|